{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T08:53:55Z","timestamp":1775292835164,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2001,8,1]],"date-time":"2001-08-01T00:00:00Z","timestamp":996624000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Autonomic Research"],"published-print":{"date-parts":[[2001,8]]},"DOI":"10.1007\/bf02298955","type":"journal-article","created":{"date-parts":[[2006,2,15]],"date-time":"2006-02-15T01:58:30Z","timestamp":1139968710000},"page":"235-242","source":"Crossref","is-referenced-by-count":96,"title":["l-threo-dihydroxyphenylserine (l-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: A multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure"],"prefix":"10.1007","volume":"11","author":[{"given":"Christopher J.","family":"Mathias","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Michel","family":"Senard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Braune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Watson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Aragishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joelle E. A.","family":"Keeling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02298955_CR1","first-page":"2131","volume-title":"Neurology in clinical practice","author":"CJ Mathias","year":"2000","unstructured":"Mathias CJ. Disorders of the autonomic nervous system. In:Neurology in clinical practice. 3rd ed. Bradley WG, Daroff RB, Fenichel GM, et al., eds. Boston: Butterworth Heinemann; 2000. pp. 2131\u20132165.","edition":"3rd ed."},{"issue":"12","key":"BF02298955_CR2","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1111\/j.1532-5415.1999.tb01566.x","volume":"47","author":"H Luukinen","year":"1999","unstructured":"Luukinen H, Herala M, Koski K, et al. Rapid increase of fall-related severe head injuries with age among older people: a population-based study.J Am Geriatr Soc 1999; 47(12):1451\u20131452.","journal-title":"J Am Geriatr Soc"},{"key":"BF02298955_CR3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1146\/annurev.med.50.1.317","volume":"50","author":"CJ Mathias","year":"1999","unstructured":"Mathias CJ, Kimber JR. Postural hypotension: causes, clinical features, investigation and management.Annu Rev Med 1999; 50:317\u2013336.","journal-title":"Annu Rev Med"},{"key":"BF02298955_CR4","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1212\/WNL.47.6.1370","volume":"47","author":"H Kaufmann","year":"1996","unstructured":"Kaufmann H. Could treatment with DOPS do for autonomic failure what DOPA did for Parkinson's disease?Neurology 1996; 47:1370\u20131371.","journal-title":"Neurology"},{"key":"BF02298955_CR5","first-page":"387","volume-title":"Autonomic failure. A textbook of clinical disorders of the autonomic nervous system","author":"CJ Mathias","year":"1999","unstructured":"Mathias CJ and Bannister R. Dopamine beta-hydroxylase deficiency. InAutonomic failure. A textbook of clinical disorders of the autonomic nervous system, 4th ed. Mathias CJ, Bannister R, eds. Oxford and New York: Oxford University Press; 1999. pp. 387\u2013401.","edition":"4th ed."},{"key":"BF02298955_CR6","first-page":"851","volume-title":"Amyloid and amyloidosis","author":"T Suzuki","year":"1988","unstructured":"Suzuki T, Azuma T, Araki S, et al. Treatment of autonomic dysfunction with L-threo-3-4-dihydroxyphenylserine (L-DOPS) in patients with familial amyloidotic polyneuropathy: A multicentre study. In:Amyloid and amyloidosis. Isobe T, Araki S, Uchino F, et al., eds. New York and London: Plenum Press; 1988. pp. 851\u2013856."},{"key":"BF02298955_CR7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0165-1838(96)00110-5","volume":"62","author":"MJ Carvalho","year":"1997","unstructured":"Carvalho MJ, van den Meiracker AH, Boomsma F, et al. Improved orthostatic tolerance in familial amyloidotic polyneuropathy with unnatural noradrenaline precursor L-threo-3,4-dihydrophenylserine.J Auton Nerv Syst 1997; 62:63\u201371.","journal-title":"J Auton Nerv Syst"},{"key":"BF02298955_CR8","first-page":"353","volume":"141","author":"I Sobue","year":"1987","unstructured":"Sobue I, Senda Y, Hirayama K, et al. Clinical pharmacological evaluation of L-threo-3-4-dihydroxyphenylserine (L-DOPS) in Shy-Drager's syndrome and its related diseases. A nation-wide double-blind comparative study.Jpn J Clin Exp Med 1987; 141:353\u2013378.","journal-title":"Jpn J Clin Exp Med"},{"issue":"9","key":"BF02298955_CR9","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1212\/WNL.53.9.2151","volume":"53","author":"R Freeman","year":"1999","unstructured":"Freeman R, Landsberg L, Young J. The treatment of neurogenic orthostatic hypotension with 3,4-DL-threo-dihydroxyphenylserine: a randomised, placebo-controlled, crossover trial.Neurology 1999; 53(9):2151\u20132157.","journal-title":"Neurology"},{"key":"BF02298955_CR10","first-page":"423","volume":"15","author":"H Narabayashi","year":"1987","unstructured":"Narabayashi H, Nakanishi T. Therapeutic effects of L-DOPS in Parkinson's disease, double-blind comparative study against placebo as control in patients with long-term levodopa therapy.Clin Eval 1987; 15:423\u2013457.","journal-title":"Clin Eval"},{"key":"BF02298955_CR11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1042\/cs0750071","volume":"75","author":"CN May","year":"1988","unstructured":"May CN, Ham IW, Heslop K, et al. Intravenous morphine causes hypertension, hyperglycaemia and increases sympatho-adrenal activity in the conscious rabbit.Clin Sci 1988; 75:71\u201377.","journal-title":"Clin Sci"},{"key":"BF02298955_CR12","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/BF00605999","volume":"23","author":"T Suzuki","year":"1982","unstructured":"Suzuki T, Higa S, Sakoda S, et al. Pharmacokinetic studies of oral L-threo-3,4-dihydroxyphenylserine in normal subjects and patients with familial amyloid polyneuropathy.Eur J Clin Pharmacol 1982; 23:463\u2013468.","journal-title":"Eur J Clin Pharmacol"},{"key":"BF02298955_CR13","unstructured":"Committee for Proprietary Medicinal Products. Points to consider on missing data.CPMP\/EWP\/1776\/99 draft. London, January 25, 2001."},{"issue":"10","key":"BF02298955_CR14","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s004150050479","volume":"246","author":"CJ Mathias","year":"1999","unstructured":"Mathias CJ, Mallipeddi R, Bleasdale-Barr K. Symptoms associated with orthostatic hypotension in pure autonomic failure and multiple system atrophy.J Neurol 1999; 246(10):893\u2013898.","journal-title":"J Neurol"},{"key":"BF02298955_CR15","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1212\/WNL.38.7.1091","volume":"38","author":"T Kachi","year":"1988","unstructured":"Kachi T, Iwase S, Mano T, et al. Effect of L-threo-3,4-dihydroxyphenylserine on muscle sympathetic nerve activity in Shy-Drager syndrome.Neurology 1988; 38:1091\u20131094.","journal-title":"Neurology"},{"key":"BF02298955_CR16","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1056\/NEJM199703063361010","volume":"10","author":"CJ Mathias","year":"1997","unstructured":"Mathias CJ. Autonomic disorders and their recognition.N Engl J Med 1997; 10:721\u2013724.","journal-title":"N Engl J Med"},{"issue":"13","key":"BF02298955_CR17","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1001\/jama.1997.03540370036033","volume":"277","author":"PA Low","year":"1997","unstructured":"Low PA, Gilden JL, Freeman R, et al. for the Midodrine Study Group. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension.JAMA 1997; 277(13):1046\u201351.","journal-title":"JAMA"}],"container-title":["Clinical Autonomic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02298955.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02298955\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02298955","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T19:31:19Z","timestamp":1557948679000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02298955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,8]]}},"alternative-id":["BF02298955"],"URL":"https:\/\/doi.org\/10.1007\/bf02298955","relation":{},"ISSN":["0959-9851","1619-1560"],"issn-type":[{"value":"0959-9851","type":"print"},{"value":"1619-1560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,8]]}}}